Quantcast

Latest Clofarabine Stories

2014-06-23 23:08:30

Mesothelioma researchers say a chemical found in the skin of red grapes is an even more powerful cancer-fighter when combined with a drug normally used to treat leukemia. Raleigh, NC (PRWEB) June 23, 2014 Surviving Mesothelioma is reacting to news that scientists in Korea have found a mesothelioma-fighting benefit to combining the red wine phenol resveratrol with a drug called clofarabine. Details on the discovery have just been posted on the Surviving Mesothelioma website. Click here to...

2013-11-26 23:29:05

Korean researchers say adding resveratrol to the treatment protocol makes mesothelioma cells more susceptible to certain kinds of drug therapy. Raleigh, NC (PRWEB) November 26, 2013 In a study published in Food and Chemical Toxicology and reported by Surviving Mesothelioma, a team of Korean cancer researchers found more evidence of the cancer-fighting power of resveratrol. Resveratrol is a natural phenol found in the skin of red grapes and plentiful in red wine and dark grape juice. It...

2010-06-14 07:00:00

PRINCETON, N.J., June 14 /PRNewswire/ -- Celator Pharmaceuticals today announced that new data from a preclinical leukemia study in mice demonstrate that its lead product, CPX-351 (Cytarabine:Daunorubicin) Liposome Injection, alone or in combination with clofarabine or azacytidine can improve treatment outcomes compared to the combination of either agent with the conventional (unencapsulated) cytarabine:daunorubicin regimen. The results were presented at the 15th Congress of the European...

2010-01-22 00:40:57

Scientists at The Royal Melbourne Hospital and the University of Melbourne in Australia have discovered the cells that cause a common type of childhood leukaemia "“ T cell Acute Lymphoblastic Leukaemia (T-ALL). Targeting of these cells may lead to improved treatments for this disease and help prevent relapse. The team, led by Dr Matthew McCormack and Dr David Curtis of the Rotary Bone Marrow Research Laboratories and the University's Department of Medicine at The Royal Melbourne...

2009-11-10 07:00:00

SOUTH SAN FRANCISCO, Calif., Nov. 10 /PRNewswire-FirstCall/ -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will present new data from nonclinical studies of voreloxin at the upcoming AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference, which is being held in Boston, MA from November 15-19, 2009. Clinical proof-of-mechanism is demonstrated in samples from patients treated with voreloxin in the Company's ongoing Phase 2 clinical study of voreloxin in...

2009-06-04 08:00:00

Combined with Clofarabine, Thiarabine Achieves High Cure Rate in a Colorectal Cancer Model DALLAS, June 4 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), announced today that new Thiarabine preclinical efficacy data will shortly be published demonstrating that thiarabine combined with clofarabine provides much greater antitumor activity than achieved by either agent alone. In one colorectal cancer model, 66% of mice were cured of their tumors. The...

2009-04-21 14:00:00

Abstract #4061 DENVER, April 21 /PRNewswire-USNewswire/ -- Scientists from the Barbara Ann Karmanos Cancer Institute in Detroit presented data today at the American Association for Cancer Research's 100th Annual Meeting 2009 that could potentially provide a brighter future for children who suffer from a more deadly form of acute leukemia. (Logo: http://www.newscom.com/cgi-bin/prnh/20071106/KARMANOSLOGO) Yubin Ge, Ph.D., and Chengzhi Xie, Ph.D., presented a poster at the conference...

2008-07-07 03:00:08

London, UK: 07 July 2008 - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announces initial findings from its phase II trial of AS1411 in relapsed and refractory AML (acute myeloid leukaemia). * Patient enrolment has been completed in the first ('lower dose') stage of the trial, in which 33 patients were randomly assigned to be treated with either 10 mg/kg/day AS1411 plus cytarabine or cytarabine alone * The addition of AS1411 at this dose to cytarabine...


Word of the Day
reremouse
  • A bat.
The word 'reremouse' comes from Middle English reremous, from Old English hrēremūs, hrērmūs ("bat"), equivalent to rear (“to move, shake, stir”) +‎ mouse.
Related